Authors: DUNCIA JV SANTELLA JB HIGLEY CA VANATTEN MK WEBER PC ALEXANDER RS KETTNER CA PRUITT JR LIAUW AY QUAN ML KNABB RM WEXLER RR

Citation: Jv. Duncia et al., PYRAZOLES, 1,2,4-TRIAZOLES, AND TETRAZOLES AS SURROGATES FOR CIS-AMIDE BONDS IN BORONATE ESTER THROMBIN INHIBITORS, Bioorganic & medicinal chemistry letters, 8(7), 1998, pp. 775-780

Authors: FEVIG JM BURIAK J CACCIOLA J ALEXANDER RS KETTNER CA KNABB RM PRUITT JR WEBER PC WEXLER RR

Citation: Jm. Fevig et al., RATIONAL DESIGN OF BOROPEPTIDE THROMBIN INHIBITORS - BETA,BETA-DIALKYLPHENETHYLGLYCINE P2 ANALOGS OF DUP-714 WITH GREATER SELECTIVITY OVER COMPLEMENT FACTOR-I AND AN IMPROVED SAFETY PROFILE, Bioorganic & medicinal chemistry letters, 8(3), 1998, pp. 301-306

Authors: QUAN ML PRUITT JR ELLIS CD LIAUW AY GALEMMO RA STOUTEN PFW WITYAK J KNABB RM THOOLEN MJ WONG PC WEXLER RR

Citation: Ml. Quan et al., BISBENZAMIDINE ISOXAZOLINE DERIVATIVES AS FACTOR XA INHIBITORS, Bioorganic & medicinal chemistry letters, 7(21), 1997, pp. 2813-2818

Authors: ZIMMERMANN PA PRUITT JR HACHAMOVITCH R

Citation: Pa. Zimmermann et al., THEOPHYLLINE THERAPY FOR COPD PATIENTS IS AN INDEPENDENT PREDICTOR FOR SUDDEN-DEATH EVENTS - POSSIBLE LINK TO PRECONDITIONING INHIBITION CAUSING AN INCREASE IN LIFE-THREATENING ARRHYTHMIAS, Circulation, 96(8), 1997, pp. 2149-2149

Authors: AUNGST BJ BLAKE JA ROGERS NJ SAITOH H HUSSAIN MA ENSINGER CL PRUITT JR

Citation: Bj. Aungst et al., PRODRUGS TO IMPROVE THE ORAL BIOAVAILABILITY OF A DIACIDIC NONPEPTIDEANGIOTENSIN-II ANTAGONIST, Pharmaceutical research, 12(5), 1995, pp. 763-767

Authors: CARINI DJ ARDECKY RJ ENSINGER CL PRUITT JR WEXLER RR WONG PC HUANG SM AUNGST BJ TIMMERMANS PBMWM

Citation: Dj. Carini et al., NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - THE DISCOVERY OF DMP-581 AND DMP-811, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 63-68